Text Size

Prevalence of Glaucoma in the Israeli Arab Population

This study is currently recruiting participants.
Verified March 2012 by Ziv Hospital
Sponsor:
Information provided by (Responsible Party):
Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01546740
First received: March 1, 2012
Last updated: March 6, 2012
Last verified: March 2012
History of Changes
  Purpose

there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.


Condition
Glaucoma

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Glaucoma Prevalence in the Israeli Arab Population

Resource links provided by NLM:

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Further study details as provided by Ziv Hospital:

Estimated Enrollment: 15000
Study Start Date: January 2012
Estimated Study Completion Date: May 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Glaucoma patients
all the ,medical records of patients who were diagnosed with primary open angle glaucoma, closed angle , pseudoexfoliative and neovascular glaucoma.

Detailed Description:

from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clinics from 1 Arab city in the center of Israel

Criteria

Inclusion Criteria:

  • Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes
  • Intraocular pressure (IOP) > 23 mm Hg
  • Damage to the field of vision
  • Age- above 20 Yrs. old

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01546740

Contacts
Contact: Joseph Pikkel, M.D +972508434206 pikel.y@ziv.health.gov.il
Contact: Otzem Chassid, M.D +972506266059 otzem.c@ziv.health.gov.il

Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel, 13120
Contact: Joseph Pikkel, M.D     +972508434206     pikel.y@ziv.health.gov.il    
Contact: Otzem Chassid, M.D     +972506266059     otzem.c@ziv.health.gov.il    
Sponsors and Collaborators
Ziv Hospital
Investigators
Principal Investigator: Joseph Pikkel, M.D Ziv Medical Center
  More Information

No publications provided

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01546740     History of Changes
Other Study ID Numbers: ZIV-0060-11
Study First Received: March 1, 2012
Last Updated: March 6, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Ziv Hospital:
Glaucoma, Compliance, Prevalence

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 16, 2013